Immunotherapy Targeting Tau Aggregation Slows Cognitive Decline in Later Stages of Alzheimer's Disease
Fight Aging!,
Immunotherapies that have successfully targeted amyloid-β have failed to help Alzheimer's patients to any meaningful degree.
Immunotherapies that have successfully targeted amyloid-β have failed to help Alzheimer's patients to any meaningful degree.
(Media News, Flickr) 9 Mar. 2021. Results from a clinical trial show treatments of electronic audio and visual impulses slow…
Results announced by the sponsors of a recently concluded phase III trial in Alzheimer's patients do not represent a cure, but…